Tag: CBT > DEA Rescheduling: Page 3

Cannabis Rescheduling

DEA Responds to ‘Out of Time’ Cannabis Rescheduling Claims

In response to cannabis advocates’ renewed motion to disqualify the DEA from the hearing process, the DEA says there is no new evidence to reconsider.

January 13, 2025

Cannabis Rescheduling

Interlocutory Appeal Could Derail Cannabis Rescheduling Hearing

New evidence prompted rescheduling advocates’ second effort to oust the DEA from the hearing; if relief is denied, they will seek the appeal.

January 8, 2025

Industry Headlines

DEA Approves Marion McNabb as Expert Witness for Cannabis Rescheduling Hearing

The doctor in public health will testify as a proponent for reclassifying cannabis to a Schedule III drug under the Controlled Substances Act.

January 7, 2025

Top Stories

Top 10 Articles of 2024: Farm Bill, Ohio Legalization, Rescheduling Lead CBT’s Coverage

Here’s a roundup of Cannabis Business Times’ most-viewed stories that readers did not want to miss out on from the past year.

December 31, 2024

Top Stories

Bat Poop Fatalities, Farm Bill Extension Lead CBT’s Top Stories in December

Illinois legislation to regulate hemp products, the DEA’s subpoena blunder and Minnesota’s unknown launch were among the most-read articles this month.

December 26, 2024

Top Stories

Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing

Administrative Law Judge John Mulrooney points out the DEA’s error yet provides the agency another shot at subpoenaing three FDA officials.

December 17, 2024

Industry Headlines

Cannabis Bioscience Fights to Include Longtime Patient as Witness in DEA Rescheduling Hearing

As a designated participant, the company filed a petition to allow testimony from Alexis Bortell, who was diagnosed with intractable epilepsy as a child.

December 16, 2024

Top Stories

The November Election Is Behind Us: Where Are We Now on Cannabis Legalization—Across the States And by the Feds?

Three of four states rejected legalization measures, and federal rescheduling remains uncertain by the Drug Enforcement Administration.

December 9, 2024

Top Stories

Attorney General Undelegated DEA’s Rescheduling Authority, Lawyers Argue; Possible Stay Could Delay Hearings

The cannabis rescheduling buck stops with the DOJ head, according to attorneys arguing that the DEA administrator cannot issue the final rule.

December 5, 2024

Home

Cannabis Rescheduling Hearing to Run Through March 2025

A Prehearing Ruling following this week’s preliminary hearing outlines the upcoming schedule and procedures, states the 43,564 public comments submitted ‘unlikely’ to be received into the hearing record.

December 4, 2024

Top Stories

DEA Counsel Dodges Question on Support for Cannabis Rescheduling

An administrative law judge asked the agency’s lead attorney the question during preliminary proceedings for an upcoming rescheduling hearing.

December 2, 2024

Top Stories

Ohio Bill to Ban Hemp Products, Trump’s AG Picks Lead CBT’s Top Stories in November

Claims that the DEA conspired with prohibitionists to manipulate the rescheduling process were also among the most-read articles this month.

December 2, 2024